Rapport Therapeutics Inc.... (RAPP)
NASDAQ: RAPP
· Real-Time Price · USD
28.92
0.38 (1.33%)
At close: Oct 03, 2025, 3:59 PM
Rapport Therapeutics Common Stock Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | n/a | n/a | 720K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 252K | 244K | n/a | 219K | 208K | 152K | 76K | n/a | 21K | 15K |
Gross Profit | -252K | -244K | 360K | -219K | -208K | -152K | -76K | n/a | -21K | -15K |
Operating Income | -29.5M | -27.11M | -23.52M | -21.64M | -20.8M | -17.09M | -14.79M | -9.56M | -6.63M | -5.19M |
Interest Income | 2.76M | 3.04M | 3.54M | 4.1M | 2.68M | 1.81M | 1.38M | 856K | 221K | 75K |
Pretax Income | -26.73M | -24.06M | -19.98M | -17.54M | -18.12M | -22.67M | -13.51M | -8.71M | -6.41M | -6.15M |
Net Income | -26.73M | -24.06M | -19.98M | -17.54M | -18.12M | -22.67M | -13.52M | -8.71M | -6.41M | -6.15M |
Selling & General & Admin | 6.82M | 7.54M | 6.32M | 6.1M | 4.9M | 4.44M | 2.92M | 1.98M | 1.89M | 1.28M |
Research & Development | 22.68M | 19.57M | 17.2M | 15.54M | 15.69M | 12.5M | 11.8M | 7.58M | 4.72M | 3.9M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 29.5M | 27.11M | 23.52M | 21.64M | 20.59M | 16.94M | 14.72M | 9.56M | 6.61M | 5.18M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -208K | -152K | -76K | n/a | -21K | -15K |
Cost & Expenses | 29.5M | 27.11M | 23.52M | 21.64M | 20.8M | 17.09M | 14.79M | 9.56M | 6.63M | 5.19M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 6K | 1K | 2K | 1K |
Shares Outstanding (Basic) | 354.45M | 192.88M | 192.88M | 191.71M | 201.17M | 194.57M | 180.79M | 190.98M | 201.17M | 194.57M |
Shares Outstanding (Diluted) | 354.45M | 192.88M | 192.88M | 191.71M | 201.17M | 194.57M | 180.79M | 190.98M | 201.17M | 194.57M |
EPS (Basic) | -0.75 | -0.12 | -0.1 | -0.09 | -0.09 | -0.12 | -0.07 | -0.05 | -0.03 | -0.03 |
EPS (Diluted) | -0.75 | -0.12 | -0.1 | -0.09 | -0.09 | -0.12 | -0.07 | -0.05 | -0.03 | -0.03 |
EBITDA | -29.5M | -27.11M | -23.26M | -21.42M | -20.59M | -16.94M | -13.34M | -9.54M | -6.61M | -5.18M |
EBIT | -26.73M | -24.06M | -23.52M | -21.64M | -20.8M | -17.09M | -13.39M | -9.56M | -6.63M | -5.19M |
Depreciation & Amortization | n/a | 244K | 260K | 219K | 208K | 152K | 53K | 23K | 21K | 15K |